Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Tivozanib/paclitaxel combination is well tolerated by patients with metastatic breast cancer

Dec. 17, 2010

Selective JAK-2 inhibitor BMS-911543 enters clinic as myelofibrosis therapy

Dec. 17, 2010

Preclinical study in MM shows activity of GNE-652 and synergism with GDC-0941

Dec. 17, 2010

ACY-1215/bortezomib combination shows promise in models of multiple myeloma

Dec. 17, 2010

AstraZeneca divulges novel ligands of androgen receptor

Dec. 17, 2010

Preliminary phase I data presented on TAK-285 in advanced cancer

Dec. 17, 2010

EpiCept's crolibulin enters phase I/II trial in anaplastic thyroid cancer

Dec. 17, 2010

Tesaro gains development rights to antiemetic rolapitant hydrochloride

Dec. 16, 2010

Orion identifies novel inhibitors of MT-SP1

Dec. 16, 2010

MGN-1601 enters phase I/II study in advanced renal cancer

Dec. 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...